Nasdaq vktx.
Viking Therapeutics Inc (NASDAQ:VKTX) shares are down by over 9% year to date bringing their 12-month return to over 142%. As of this writing, Viking Therapeutics shares are trading at around $8.60 with a 52-week range of $2.02 to $9.62, giving the company a market capitalization of more than $660 million. Summit Therapeutics (257%)
Here's why they chose Bluebird Bio (NASDAQ: BLUE), Travere Therapeutics (NASDAQ: TVTX), and Viking Therapeutics (NASDAQ: VKTX). The upside is huge, but beware of the risks .Viking Therapeutics Inc (NASDAQ:VKTX) shares are down by over 9% year to date bringing their 12-month return to over 142%. As of this writing, Viking Therapeutics shares are trading at around $8.60 with a 52-week range of $2.02 to $9.62, giving the company a market capitalization of more than $660 million. Summit Therapeutics (257%)03 Nov, 2021, 16:05 ET. SAN DIEGO, Nov. 3, 2021 /PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX ), a clinical-stage biopharmaceutical company focused on the development of novel ...Viking Therapeutics, Inc. (NASDAQ: VKTX) is an American biotechnology company that is focused on the development of novel and orally available therapies for the treatment of metabolic and ...Shares of clinical-stage biotech Viking Therapeutics ( VKTX 6.68%) fell by as much as 4.8% on exceptionally low volume during the first hour of trading Tuesday morning. Since this mid-single-digit ...
(NASDAQ: VKTX) Viking Therapeutics's 52-week high was $25.72, and its 52-week low was $3.54. It is currently -49.42% from its 52-week high and 267.51% from its ...About Institutional Holdings. Nasdaq provides the ownership stake information in a company, including the number of shares held by those institutions in a firm, along with recent purchases and ...
Morphic Holding Inc. 23.40. +0.29. +1.25%. Get Viking Therapeutics Inc (VKTX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company’s lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb …Shares of clinical-stage biotech Viking Therapeutics ( VKTX 6.68%) fell by as much as 4.8% on exceptionally low volume during the first hour of trading Tuesday morning. Since this mid-single-digit ...Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.Discover historical prices for VKTX stock on Yahoo Finance. View daily, weekly or monthly format back to when Viking Therapeutics, Inc. stock was issued. Price Volume Sep '23 Oct '23 Nov '23 Dec '23 $10 $8 $12 $14 $16 $18 0M 10M 20M 2020. Display Events. Dividends. Splits. Earnings. News. Chart Style. Line. Mountain.
SAN DIEGO, Nov. 9, 2021 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic ...
In the last 3 months, 9 analysts have offered 12-month price targets for Viking Therapeutics. The company has an average price target of $33.0 with a high of $40.00 and a low of $24.00. Below is a ...
Financial News. View the latest Viking Therapeutics Inc. (VKTX) stock price, news, historical charts, analyst ratings and financial information from WSJ.Fintel reports that on May 16, 2023, BTIG maintained coverage of Viking Therapeutics (NASDAQ:VKTX) with a Buy recommendation.. Analyst Price Forecast Suggests 35.91% Upside. As of May 11, 2023 ...View real-time VKTX stock price and news, ... Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones. ETF Movers: Includes ETFs & ETNs with volume of at least 50,000.Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) have received an average rating of “Buy” from the nine analysts that are presently covering the stock, MarketBeat Ratings reports. Nine analysts have rated the stock with a buy recommendation. The average 12 month target price among brokers that have covered the stock in the […]Viking Therapeutics. Market Cap. $1B. Today's Change. (1.85%) $0.21. Current Price. $11.56. Price as of November 22, 2023, 4:00 p.m. ET. You’re reading a free article with opinions that may ...
Back to VKTX Overview About Latest Pre-Market Trades Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day. 03 Nov, 2021, 16:05 ET. SAN DIEGO, Nov. 3, 2021 /PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX ), a clinical-stage biopharmaceutical company focused on the development of novel ...Jan 3, 2023 · Rasi Bhadramani. Viking Therapeutics (NASDAQ:VKTX) has been my top NASH stock for the past few years due to VK2809's performance, the company's cash position, and the reasonable valuation ... VKTX Stock 12 Months Forecast. $34.00. (187.40% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Viking Therapeutics in the last 3 months. The average price target is $34.00 with a high forecast of $40.00 and a low forecast of $28.00. The average price target represents a 187.40% change from the last price of $11.83.Dec 14, 2022 · Viking Therapeutics (NASDAQ:VKTX) is a great speculative biotech play to look into. The reason why I state that is because I believe it has huge potential as a long-term play. Dec 1, 2023 · According to the issued ratings of 9 analysts in the last year, the consensus rating for Viking Therapeutics stock is Buy based on the current 9 buy ratings for VKTX. The average twelve-month price prediction for Viking Therapeutics is $30.25 with a high price target of $37.00 and a low price target of $19.00.
Find the latest Earnings Report Date for Viking Therapeutics, Inc. Common Stock (VKTX) at Nasdaq.com.
Viking Therapeutics, Inc. (NASDAQ:VKTX), based in San Diego, California, is a clinical-stage company focused on the development of first-in-class or best-in-class therapies for metabolic and ...SAN DIEGO, Nov. 2, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic ...Viking Therapeutics, Inc. VKTX NASDAQ.Viking Therapeutics, Inc. (NASDAQ:VKTX) is favoured by institutional owners who hold 74% of the company.Viking Therapeutics, Inc. (NASDAQ:VKTX) insiders who bought shares over the past year were rewarded handsomely last week. The stock rose 8.7%, resulting in a US$167m rise in the company's market ...Viking Therapeutics, Inc. (NASDAQ:VKTX), based in San Diego, California, is a clinical-stage company focused on the development of first-in-class or best-in-class therapies for metabolic and ...
Dec 1, 2023 · Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock. SAN DIEGO , March 29, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic a... 8 months ago - PRNewsWire.
SAN DIEGO, May 16, 2022 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic ...
Viking Therapeutics (NASDAQ: VKTX) has had a very promising 2023.They announced very good early results for an obesity drug in March. They then quickly used those good results to sell $250 million ...02 Feb, 2018, 08:33 ET. SAN DIEGO, Feb. 2, 2018 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX ), a clinical-stage biopharmaceutical company focused on the development of novel ...Of the funds tracked by Insider Monkey, Peter S. Park's Park West Asset Management has the largest position in Viking Therapeutics, Inc. (NASDAQ:VKTX), worth close to $12 million, accounting for 0 ...Stock Activity Open 12.40 Day Low 11.82 Day High 13.10 52 Wk Low 3.54 52 Wk High 25.72 Avg. Volume 1,501,039 Market Cap 1.22 B Dividend 0.00 ( 0.00%) Beta …VKTX NASDAQ. VKTX NASDAQ. VKTX NASDAQ. Market closed Market closed. No trades. See on Supercharts. Overview News Ideas Financials Technicals . Forecast . Price target. 33.80 0.00 0.00%. The 10 analysts offering 1 year price forecasts for VKTX have a max estimate of — and a min estimate of —.Turning to the calls side of the option chain, the call contract at the $18.00 strike price has a current bid of $1.05. If an investor was to purchase shares of VKTX stock at the current price ...Viking Therapeutics (NASDAQ:VKTX) is a great speculative biotech play to look into. The reason why I state that is because I believe it has huge potential as a long-term play.About Latest Pre-Market Trades. Nasdaq provides market information opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day. See Also. Nasdaq MarketSIte. Do Not Sell …9 brokers have issued 1 year target prices for Viking Therapeutics' shares. Their VKTX share price targets range from $19.00 to $37.00. On average, they predict the company's stock price to reach $30.25 in the next twelve months. This suggests a possible upside of 132.5% from the stock's current price.
Mar. 28, 2023, 08:37 AM. Viking Therapeutics Inc (NASDAQ:VKTX) shares are trading higher Tuesday after the company reported results from its Phase 1 trial of VK2735 for the potential treatment of ...Study Enrollment and Dosing to Resume. SAN DIEGO, July 19, 2022 /PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the FDA has lifted the clinical hold …Today's Change. (1.85%) $0.21. Current Price. $11.56. Price as of November 22, 2023, 4:00 p.m. ET. You’re reading a free article with opinions that may differ from The Motley Fool’s Premium ...During the last session, Viking Therapeutics Inc (NASDAQ:VKTX)’s traded shares were 1.77 million, with the beta value of the company hitting 0.59. At the end of the trading day, the stock’s price was $12.22, reflecting an intraday gain of 3.30% or $0.39. The 52-week high for the VKTX share is $ ...Instagram:https://instagram. steel penneybest art insurance companiescambel soupmortgage lenders washington state VKTX VKTX AFTER HOURS QUOTE VKTX LATEST AFTER HOURS TRADES. ... Add symbols now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing stocks, funds and ETFs, ...Shares of NASDAQ VKTX opened at $13.01 on Monday. Viking Therapeutics has a 12 month low of $3.54 and a 12 month high of $25.72. The stock has a 50 day moving average of $10.86 and a 200-day ... legal and general reviewsbnd vanguard SAN DIEGO, July 27, 2022 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX ), a clinical-stage biopharmaceutical company focused on the development of novel therapies for ... free s23 ultra VKTX VKTX AFTER HOURS QUOTE VKTX LATEST AFTER HOURS TRADES. ... Add symbols now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing stocks, funds and ETFs, ...Mar 30, 2023 · Shares of Viking Therapeutics ( VKTX 6.23%) were up 89.7% for the week as of Thursday afternoon, after being up as much as 95.5% for the week, according to data provided by S&P Global Market ...